MétaCan
Menu
Retour à la cohorte
Enregistrement W2949625461 · doi:10.1002/hep.30256

Oral Abstracts (Abstracts 1–299)

2018· article· en· W2949625461 sur OpenAlexfundno aff

Notice bibliographique

RevueHepatology · 2018
Typearticle
Langueen
DomaineBiochemistry, Genetics and Molecular Biology
ThématiqueMetabolism and Genetic Disorders
Établissements canadiensnon disponible
Organismes subventionnairesInstitute of GeneticsNIHR Nottingham Biomedical Research CentreErasmus Universitair Medisch Centrum RotterdamSchool of Medicine, Indiana UniversityNovartis PharmaUniversity of California, San FranciscoAllerganMedical Center, University of PittsburghSamsungUniversitätsklinikum KölnTaipei Veterans General HospitalSouthwest HospitalFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversità degli Studi di MessinaLabex Immuno-OncologyNagoya City UniversityPomorski Uniwersytet Medyczny W SzczecinieChina Medical UniversityUniversità degli Studi di TorinoAristotle University of ThessalonikiHospital for Sick ChildrenHouston Methodist Research InstituteFakultet Medicinskih Nauka, Univerziteta U KragujevcuMedizinische Universität WienResearch Committee, Aristotle University of ThessalonikiUniversitat de BarcelonaZhongnan Hospital of Wuhan UniversityUniversité Paris DiderotUniversidade de São PauloUniverza v LjubljaniUniversité Paris DescartesNational Yang-Ming UniversityNational and Kapodistrian University of AthensUniversiti MalayaSeoul National University HospitalMahidol UniversityOchsner HealthUniversité de StrasbourgCincinnati Children's Hospital Medical CenterUniversität WienDavid Geffen School of Medicine, University of California, Los AngelesCentre Hospitalier Universitaire de BordeauxKaohsiung Medical UniversityCollege of Medicine, University of CincinnatiUniversität BaselEulji UniversityUniversity of ThessalyKing Faisal Specialist Hospital and Research CentreInstitut National de la Santé et de la Recherche MédicaleChildren's Hospital Los AngelesUniversity College DublinSingapore General HospitalNational University of SingaporeChina Medical University HospitalUniversity of OxfordSchool of Medicine, Emory UniversityKing's College LondonSungkyunkwan UniversityHallym UniversityNational Institute for Health and Care ResearchSapienza Università di RomaGenomics Research Center, Academia SinicaCatholic University of KoreaIntercept PharmaceuticalsInselspital, Universitätsspital BernInje UniversityChildren's National HospitalUniversity of BernUniversity of PittsburghTeikyo University School of MedicineHanyang UniversityUniversité Paris 13Université de LilleNational Taiwan University HospitalUniversità degli Studi di FirenzePfizerKaohsiung Medical University Chung-Ho Memorial HospitalWuhan UniversityUniversity of WashingtonUniversità degli Studi di MilanoSeattle Children's Research InstituteNational Taiwan UniversityUniversidad de SevillaNGM BiopharmaceuticalsUniversity of California, San DiegoUniversity of CincinnatiTel Aviv UniversityCystic Fibrosis FoundationKyungpook National UniversityUniversity of New South WalesCleveland ClinicUniversità degli Studi di PalermoHouston Methodist HospitalJohns Hopkins UniversityFaculty of Medical Sciences, Newcastle UniversityUniversity of North Carolina at Chapel HillChildren's Healthcare of AtlantaAlexion PharmaceuticalsHuazhong University of Science and TechnologySoutheast UniversitySemmelweis EgyetemSaint Louis UniversityBristol-Myers SquibbHelsingin YliopistoAnkara UniversitesiBaylor UniversityShireUniversité de Reims Champagne-ArdenneIcahn School of Medicine at Mount SinaiPusan National UniversityPalo Alto Medical FoundationEli Lilly and CompanyChildren's Hospital of PittsburghUniversity of AlbertaUniversità degli Studi di Napoli Federico IIBaylor University Medical CenterArmy Medical UniversityVirginia Commonwealth UniversityUppsala UniversitetRush UniversityFeinberg School of MedicineUniversity of Texas Health Science Center at HoustonYale UniversityTexas Children's HospitalAcademia SinicaEmory UniversityUniversità degli Studi di Roma Tor VergataOhio State UniversityWeill Cornell Medical CollegeUniversity of PennsylvaniaUniversity of Colorado School of Medicine, Anschutz Medical CampusExelixisChildren's Hospital of PhiladelphiaTongji UniversityAlnylam PharmaceuticalsYork UniversityChildren's Hospital ColoradoFaculty of Medicine Siriraj Hospital, Mahidol UniversityEisaiInstitució Catalana de Recerca i Estudis AvançatsUniversity of Southern CaliforniaGilead SciencesUniversity of RochesterPeking University People's HospitalUniversitair Medisch Centrum GroningenNewcastle UniversityPeking UniversitySeoul National UniversityNorthwestern UniversityAmerican Association for the Study of Liver DiseasesUniversity of TorontoAmerican Porphyria FoundationNational Institutes of HealthChinese University of Hong KongMassachusetts General HospitalÖsterreichischen Akademie der WissenschaftenAssistance publique-Hôpitaux de ParisAudentes TherapeuticsTongji Medical College, Huazhong University of Science and TechnologyGlaxoSmithKlineQueen Mary University of London
Mots-clésMedicine

Résumé

récupéré en direct d'OpenAlex

Background: Surgeons frequently reject high-risk donor livers, which currently comprise the only increasing and underutilised donor resource. The VITTAL trial assessed "transplantability" of discarded livers with NMP and evaluated 90-day outcomes in these grafts. Methods: This prospective, single-arm phase 2 trial included deceased donor livers, discarded by all UK centres, that met at least one of the following criteria (donor risk index 2.0, macrosteatosis 30%, ALT/AST 1000IU/mL, donor WIT 30mins in DCD livers, poor perfusion or anticipated CIT 12 for DBD or 8hrs for DCD livers. Recipients included consented adults undergoing primary transplantation, with a UKELD score 62, without portal vein thrombosis or significant cardiovascular comorbidity. Livers clearing lactate to 2.5mmol/L within 4 hours of NMP and meeting two other criteria (good arterial/ venous flow, bile production, homogenous perfusion, pH improvement) were deemed transplantable. The primary endpoints were liver salvage success rate and recipient 90day survival. Results: Over 15 months, 185 retrieved livers were discarded for clinical use (Figure Donor inclusion criteria were not met in 25, 21 were offered when the NMP machine was being used, and there were no suitable recipients for 41. Thirty-one livers (14 DCD) were included in the trial. Donor age was 57yrs(30-84), BMI 29kg/ m 2 (20-42), DRI 2.2(1.2-3.8), liver weight 1.8kg(1.2-2.6) and the CIT was 7.33hrs(5:17-14:50) [median (range)]. Of these, 22(71%) livers were transplanted after meeting viability criteria. The total preservation time was 17:53hrs(11:21-25:32). Patient and graft 90-day survival were 100%. Seven (32%) patients developed early allograft dysfunction, and 5(23%) patients developed Clavien-Dindo complication grade 3, including 4(18%) cases with acute kidney injury requiring renal replacement therapy. The median intensive care and in-hospital stay were 3 days (2-39) and 10 days (6-47) respectively. Conclusion: Viability testing of discarded livers with NMP is feasible and predicts early post-transplant function.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,548
Score d'incertitude au seuil0,712

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,001

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,013
Tête enseignante GPT0,269
Écart entre enseignants0,256 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations26
Publié2018
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueHepatologyMême sujetMetabolism and Genetic DisordersTravaux en français237 207